May 1, 2025   SOURCE: PR NewsWire

In Vitro Diagnostics: Technologies Transforming Global Healthcare Markets

"In vitro diagnostics (IVD) refers to tests performed outside the body to detect diseases, monitor health, or guide treatments. These technologies are revolutionizing global healthcare by enabling early diagnosis, personalized medicine, and improved patient outcomes."

BOSTON, May 1, 2025 /PRNewswire/ -- According to the latest study from BCC Research, In Vitro Diagnostics: Technologies and Global Markets is projected to grow from $94.7 billion in 2024 to $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.Boston: According to the latest study from BCC Research, In Vitro Diagnostics: Technologies and Global Markets is projected to grow from $94.7 billion in 2024 to $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

This report analyzes in vitro diagnostic (IVD) technologies and devices used in hospitals and point-of-care (POC) settings, focusing on market trends, drivers, opportunities, and competitive intelligence. It segments the market by technology, application, end user, and region, with forecasts through 2029.

Interesting facts:

    --  Artificial Intelligence (AI) has revolutionized the healthcare industry.
        The report explores how companies are integrating AI into IVD devices.
    --  POC testing is increasingly used over traditional hospital and
        clinic-based diagnostics, with demand surging post-pandemic.
    --  Haematology remains a widely practiced test type compared to diagnostic
        microbiology, driven by a global rise in blood-related disorders.

Factors contributing to the market's growth include:

    1. Rise in the population of older adults and dependency on frequent
       diagnosis procedures: The growing number of older adults is increasing
       the need for frequent diagnostic procedures to manage age-related health
       conditions. This trend is driving demand for advanced and accessible
       diagnostic solutions.
    2. Integration of artificial intelligence in IVD: AI is being integrated
       into in vitro diagnostics to improve the accuracy and speed of disease
       detection. This technology helps provide more personalized and efficient
       healthcare solutions.
    3. Rising incidence of chronic diseases: The rising incidence of chronic
       diseases, such as diabetes and heart conditions, is increasing the need
       for ongoing monitoring and diagnostic tests. This trend is fueling the
       demand for advanced diagnostic technologies.
    4. Improving the quality of POC testing: This is making health diagnostics
       faster, more accurate, and easily accessible, especially in remote or
       urgent care settings.

Request a Sample Copy of the In Vitro Diagnostics: Technologies and Global Markets

Report Synopsis



     
              Report Metric   
     
              Details



     Base year considered                                                     2023



     Forecast period considered 
     2024-2029



     Base year market size                                  
            $87.8 billion



     Market size forecast                                  
            $141.9 billion



     Growth rate                  CAGR of 8.4% for the forecast period of
                                    2024-2029



     Segments covered             Technology, product, application, end user,
                                    region



     Regions covered              North America, Europe, Asia-Pacific, Latin
                                    America,

                                 
     Middle East and Africa



     Countries covered            U.S., Canada, Mexico, China, Japan, India,
                                    Australia and

                                   New Zealand, Germany, Italy, France, U.K.,
                                    Spain, Brazil,

                                 
     Argentina, and South Africa



     Market drivers                --  Rise in the population of older adults and

                                       dependency on frequent diagnosis procedures.

                                 
      --  Integration of AI in IVD.

                                    --  Rising incidence of chronic diseases.

                                    --   Improving the quality of point-of-care
                                     testing.

Questions Addressed:

    1. What is the projected market size and growth rate?The market is projected
       to grow from $87.8 billion in 2023 to $141.9 billion by the end of 2029,
       at a compound annual growth rate (CAGR) of 8.4% during the forecast
       period.

    2. What are the factors driving the growth of the market?Rise in the aging
       population and dependency on frequent diagnosis procedures, Integration
       of AI in IVD, rising incidence of chronic diseases and improving the
       quality of POC testing.

    3. What market segments are covered in the report?The market is segmented by
       technology, application and end user.

    4. Which technology segment will be dominant over the forecast period?The
       haematology segment is anticipated to dominate the market through the end
       of 2029.

    5. Which region has the largest market share?North America holds the largest
       market share.

Market leaders include:

    --  Abbott
    --  Becton, Dickinson and Co.
    --  Biomerieux
    --  Bio-Rad Laboratories Inc.
    --  Bio-Techne
    --  Bruker
    --  Danaher Corp.
    --  EKF Diagnostics Holdings Plc
    --  F. Hoffmann-La Roche Ltd.
    --  Hologic Inc.
    --  JSR Corp.
    --  Quidelortho Corp.
    --  Siemens Healthineers AG
    --  Sysmex Corp.
    --  Thermo Fisher Scientific Inc.

Related reports include:

In Vitro Diagnostics (IVD) Quality Controls: Global Market: The global market for in vitro diagnostics (IVD) quality controls focuses on ensuring the accuracy and reliability of diagnostic tests. As demand for precise diagnostics grows, the need for high-quality control systems in IVD devices is growing worldwide.

In Vitro Diagnostics (IVD) Analyzers: Global Market: The global market for IVD analyzers is driven by the rising demand for efficient and accurate diagnostic testing. These analyzers play a crucial role in disease detection and monitoring.

Purchase a copy of the report direct from BCC Research.

For further information on these reports or to purchase one, please contact info@bccresearch.com.

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-vitro-diagnostics-technologies-transforming-global-healthcare-markets-302444470.html

SOURCE BCC Research LLC